273931-53-6 Usage
Uses
1. Used in Research Applications:
1-Myristoyl-2-(4-nitrophenylsuccinyl)-sn-glycero-3-phosphocholine is used as a research chemical for studying the properties and functions of lipids in biological systems. Its unique structure allows researchers to investigate various aspects of lipid metabolism, membrane dynamics, and cell signaling.
2. Used in Pharmaceutical Industry:
In the pharmaceutical industry, 1-Myristoyl-2-(4-nitrophenylsuccinyl)-sn-glycero-3-phosphocholine may be used as a starting material or intermediate in the synthesis of novel drug candidates targeting lipid-related diseases or conditions. Its specific structural features could potentially be exploited to develop targeted therapies for various medical applications.
3. Used in Analytical Chemistry:
1-Myristoyl-2-(4-nitrophenylsuccinyl)-sn-glycero-3-phosphocholine can also be employed in analytical chemistry as a reference compound or standard for the development and validation of analytical methods, such as chromatography or mass spectrometry, for the detection and quantification of similar lipid molecules in biological samples.
4. Used in Material Science:
The unique properties of 1-Myristoyl-2-(4-nitrophenylsuccinyl)-sn-glycero-3-phosphocholine may also find applications in material science, particularly in the development of novel materials with specific properties, such as self-assembly, amphiphilic behavior, or controlled release of active agents.
Check Digit Verification of cas no
The CAS Registry Mumber 273931-53-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,7,3,9,3 and 1 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 273931-53:
(8*2)+(7*7)+(6*3)+(5*9)+(4*3)+(3*1)+(2*5)+(1*3)=156
156 % 10 = 6
So 273931-53-6 is a valid CAS Registry Number.
273931-53-6Relevant articles and documents
Method for synthesizing platelet activating factor (PAF) analog
-
, (2019/11/28)
The invention discloses a method for synthesizing a platelet activating factor (PAF) analog which is of a formula shown in the specification from glyceryl phosphoryl choline as a raw material according to scheme of the following three steps of reactions: 1, enabling glyceryl phosphoryl choline, a hydroxyl activator and an aliphatic hydrocarbon carbonyl compound to react to generate an intermediate1; 2, enabling the intermediate 1 to react with cyclic anhydride to generate an intermediate 2; and 3, enabling the intermediate 2 to react with nitrophenol and a condensing agent to generate a product, namely the PAF analog. In the step 1, the glyceryl phosphoryl choline is adopted as a reaction initializing raw material, and a series of PAF analogs can be derived; in the step 2, a catalyst is additionally used, so that the yield can be increased; and in the step 3, a condensing agent which is gentle in reaction condition is selected, so that reaction steps can be reduced, an acyl chloride intermediate which is good in corrosiveness and easy to dehydrate is not generated, and equipment consumption can be reduced.
